GlassScriptPhysician profile
James R Mcatee
NPI 1922005354
$3,553.65
in general payments reported to CMS, 2019-2025
5 companies · $3,093 in 2025
The $3,093 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.61 · 2020: $18.87 · 2021: $197 · 2022: $108 · 2023: $34.30 · 2024: $17.50 · 2025: $3,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,052 · Food and Beverage: $92.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,051.68 |
| Food and Beverage | $92.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $3,051.68 | 2025 | Ha Minuteman G3-R |
| Vericel Corporation | $204.18 | 2020-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $140.52 | 2021-2022 | |
| Acumed LLC | $126.81 | 2019-2025 | Innate Implant |
| Stryker Corporation | $30.46 | 2023-2024 | Omega, Chromophare F300 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,480,738.80 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcatee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.